Background illustration for clinical trials search

Paid Clinical Trials Los Angeles

Discover 3,587 paid clinical trials in Los Angeles, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Ca-Mg Butyrate in Gulf War Illness

for
Gulf War Illness, Chronic Fatigue, Neurocognitive Dysfunction
Location: Long Beach CA, Salt Lake City UT, Miami FL
Sponsor: VA Office of Research and Development

Sex: All

Age: 40 - 70

Code: NCT05367245

Phase 2, Recruiting

Bromelain, Comosain as a New Drug for Treating and Preventing Various Types of Cancer in the Humans

for
Cancer
Location: West Covina CA
Sponsor: Oeyama-Moto Cancer Research Foundation

Sex: All

Age: 18 - 70+

Code: NCT02340845

Phase 2, Recruiting

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Los Angeles CA, Bellflower CA, Panorama City CA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 65+

Code: NCT07321652

Phase 3, Recruiting

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

for
Migraine
Location: Hawthorne CA, Boise ID, Grand Island NE, San Antonio TX,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT05156398

Phase 3, Recruiting

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

for
Schizophrenia, Schizo-Affective Disorder,
Location: Anaheim CA, DeSoto TX, Decatur GA, Hialeah FL
Sponsor: BioXcel Therapeutics Inc

Sex: All

Age: 10 - 17

Code: NCT05025605

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Long Beach CA, Reno NV, Portland OR, Olympia WA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05947851

Phase 3, Recruiting

Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)

for
Obesity, Bariatric Surgery, Sleeve Gastrectomy,
Location: Orange CA, San Diego CA
Sponsor: University of California, Irvine

Sex: All

Age: 18 - 65

Code: NCT06783751

Recruiting

Outpatient Labor Induction With the Transcervical Foley Balloon

for
Pregnancy, Labor; Forced or Induced, Affecting Fetus or Newborn
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: Female

Age: 18+

Code: NCT02210598

Recruiting

Determining the Role of Social Reward Learning in Social Anhedonia

for
Psychosis
Location: Los Angeles CA, Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18 - 35

Code: NCT05617898

Recruiting

Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset

for
Infant, Extremely Premature, Obstetric Labor, Premature,
Location: Long Beach CA, Orange CA, Loma Linda CA, San Diego CA,
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 0 - 1

Code: NCT05685745

Recruiting

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for
Diffuse Large B-Cell Lymphoma
Location: Los Angeles CA, Long Beach CA, Los Alamitos CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06717347

Phase 3, Recruiting

Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease

for
Degenerative Disc Disease, Disc Degeneration,
Location: Santa Monica CA, Napa CA, Reno NV, Eugene OR,
Sponsor: VIVEX Biologics, Inc.

Sex: All

Age: 22 - 70+

Code: NCT06778447

Recruiting

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

for
Locally Advanced Cervical Adenocarcinoma,
Location: Los Angeles CA, South Pasadena CA, Bellflower CA,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07061977

Phase 3, Recruiting

QTX3034 in Patients With KRAS G12D Mutation

for
Solid Tumors
Location: Los Angeles CA, Salt Lake City UT, Denver CO,
Sponsor: Quanta Therapeutics

Sex: All

Age: 18+

Code: NCT06227377

Phase 1, Recruiting

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

for
Intracerebral Hemorrhage
Location: Los Angeles CA, Downey CA, Baldwin Park CA,
Sponsor: Joseph Broderick, MD

Sex: All

Age: 18 - 70+

Code: NCT07227246

Phase 3, Recruiting

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

for
Heart Failure, Acute Heart Failure
Location: Los Angeles CA, Van Nuys CA, Tarzana CA, West Hills CA,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06008197

Phase 3, Recruiting

A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults

for
Respiratory Syncytial Virus (RSV)
Location: Los Angeles CA, DeSoto TX, Iowa City IA, St Louis MO,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07768345

Phase 3, Recruiting

Pilot Study of Raltegravir Lipodystrophy IISP

for
HIV Infection
Location: Long Beach CA
Sponsor: Southern California Institute for Research and Education

Sex: All

Age: 0+

Code: NCT01164605

Recruiting

Safety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic Melanoma

for
Metastatic Melanoma
Location: Newport Beach CA, Irvine CA
Sponsor: Aivita Biomedical, Inc.

Sex: All

Age: 18+

Code: NCT03743298

Phase 1, Recruiting

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

for
B-cell Acute Lymphoblastic Leukemia
Location: Los Angeles CA, Denver CO, Aurora CO, San Antonio TX,
Sponsor: Cellectis S.A.

Sex: All

Age: 15 - 50

Code: NCT04150497

Phase 1, Phase 2, Recruiting

With a vast healthcare network and top-tier medical research centers, Los Angeles is a key hub for a wide range of clinical trials. Renowned institutions such as UCLA Health, Cedars-Sinai Medical Center, and the Keck School of Medicine at USC lead pioneering research across various fields, including cancer, cardiovascular health, and neuroscience.

Many Los Angeles medical centers are at the forefront of innovative studies, positioning the city as a critical location for advancing medical research and improving patient care outcomes.

Why choose Los Angeles for clinical trials?

Los Angeles offers distinct advantages for individuals participating in clinical trials. The city’s diverse population provides a wide range of participants, enhancing the accuracy and applicability of research findings across different demographics.

Known for its forward-thinking research environment, Los Angeles is home to leading institutions that drive cutting-edge studies in a variety of medical fields. By choosing to participate in a clinical trial in Los Angeles, individuals contribute to groundbreaking medical research while benefiting from the city's well-established clinical research infrastructure and access to world-class healthcare professionals.

Common conditions studied in Los Angeles

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Los Angeles